Study type: Human research · Status: Verified against declared source

Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study.

Medicina (Kaunas, Lithuania) · 2025

Study scale: Background and Objectives: Acute ischemic stroke is a major cause of disability and mortality.

Abstract only: Open source record

Product or molecular entity relationships

Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Background and Objectives: Acute ischemic stroke is a major cause of disability and mortality.

Methods

Background and Objectives: Acute ischemic stroke is a major cause of disability and mortality.

Scale or participants

Background and Objectives: Acute ischemic stroke is a major cause of disability and mortality.

Key findings

Background and Objectives: Acute ischemic stroke is a major cause of disability and mortality.

Limitations and uncertainty

Background and Objectives: Acute ischemic stroke is a major cause of disability and mortality.

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.